Physician profile
Marc D Ricks
NPI 1669613089
$152.57
in general payments reported to CMS, 2019-2025
5 companies · $19.28 in 2025
The $19.28 reported for 2025 was less than what a typical Pediatrics provider received nationally (typical 2025 total: $96.93).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $89.52 · 2021: $23.80 · 2022: $19.97 · 2025: $19.28.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $19.28.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $19.28 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals Lp | $65.88 | 2019 | |
| Merck Sharp & Dohme LLC | $30.82 | 2019-2025 | |
| Takeda Pharmaceuticals U.S.A., INC. | $23.80 | 2021 | |
| Phadia US INC. | $19.97 | 2022 | |
| Novo Nordisk INC | $12.10 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Marc Ricks listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.